European Journal of Nutrition

, Volume 53, Issue 8, pp 1591–1601 | Cite as

Body mass index and the risk of gout: a systematic review and dose–response meta-analysis of prospective studies

  • Dagfinn AuneEmail author
  • Teresa Norat
  • Lars J. Vatten



Greater body fatness has been associated with increased risk of gout in several studies; however, the strength of the association has differed between studies, and it is not clear whether the association differs by gender. We conducted a systematic review and meta-analysis of prospective studies to clarify the association between adiposity and risk of gout.


PubMed and Embase were searched up to August 30, 2013. Summary relative risks (RRs) were calculated using a random effects model.


Ten prospective studies of body mass index (BMI) and gout risk with 27,944 cases and 215,739 participants were included (median follow-up 10.5 years). The summary RR for a 5 unit increment was 1.55 [95 % confidence interval (95 % CI) 1.44–1.66, I 2 = 67 %] for all studies combined. The heterogeneity was explained by one study, which appeared to be an outlier. The summary RR per 5 BMI units was 1.62 (95 % CI 1.33–1.98, I 2 = 79 %) for men and 1.49 (95 % CI 1.32–1.68, I 2 = 30 %) for women, p heterogeneity = 0.72. The relative risks were 1.78, 2.67, 3.62, and 4.64 for persons with BMI 25, 30, 35, and 40 compared with persons with a BMI of 20. BMI in young adulthood, waist-to-hip ratio, and weight gain from age 21–25 to midlife were also associated with increased risk, but few studies were included in these analyses.


Greater body mass index increases risk of gout. Further studies are needed on adiposity throughout the life course, waist-to-hip ratio, and weight changes in relation to gout as there were few studies that had published on these exposures.


Body mass index Waist-to-hip ratio Weight gain Gout Meta-analysis 



This project has been supported by the “Liaison Committee between the Central Norway Regional Health Authority (RHA) and the Norwegian University of Science and Technology (NTNU).” The funding agency had no role in the conception and design of the study, the planning or conduct of the analyses, writing or revision of the manuscript.

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical standards

The manuscript does not contain clinical studies or patient data.

Supplementary material

394_2014_766_MOESM1_ESM.pdf (257 kb)
Supplementary material 1 (PDF 257 kb)


  1. 1.
    Zhu Y, Pandya BJ, Choi HK (2011) Prevalence of gout and hyperuricemia in the US general population: the National Health and Nutrition Examination Survey 2007–2008. Arthritis Rheum 63:3136–3141CrossRefGoogle Scholar
  2. 2.
    Chen JH, Yeh WT, Chuang SY, Wu YY, Pan WH (2012) Gender-specific risk factors for incident gout: a prospective cohort study. Clin Rheumatol 31:239–245CrossRefGoogle Scholar
  3. 3.
    Wallace KL, Riedel AA, Joseph-Ridge N, Wortmann R (2004) Increasing prevalence of gout and hyperuricemia over 10 years among older adults in a managed care population. J Rheumatol 31:1582–1587Google Scholar
  4. 4.
    Arromdee E, Michet CJ, Crowson CS, O’Fallon WM, Gabriel SE (2002) Epidemiology of gout: is the incidence rising? J Rheumatol 29:2403–2406Google Scholar
  5. 5.
    Chuang SY, Lee SC, Hsieh YT, Pan WH (2011) Trends in hyperuricemia and gout prevalence: nutrition and Health Survey in Taiwan from 1993-1996 to 2005-2008. Asia Pac J Clin Nutr 20:301–308Google Scholar
  6. 6.
    Campion EW, Glynn RJ, DeLabry LO (1987) Asymptomatic hyperuricemia. Risks and consequences in the Normative Aging Study. Am J Med 82:421–426CrossRefGoogle Scholar
  7. 7.
    Roubenoff R, Klag MJ, Mead LA, Liang KY, Seidler AJ, Hochberg MC (1991) Incidence and risk factors for gout in white men. JAMA 266:3004–3007CrossRefGoogle Scholar
  8. 8.
    Choi HK, Atkinson K, Karlson EW, Curhan G (2005) Obesity, weight change, hypertension, diuretic use, and risk of gout in men: the health professionals follow-up study. Arch Intern Med 165:742–748CrossRefGoogle Scholar
  9. 9.
    Williams PT (2008) Effects of diet, physical activity and performance, and body weight on incident gout in ostensibly healthy, vigorously active men. Am J Clin Nutr 87:1480–1487Google Scholar
  10. 10.
    Bhole V, de Vera M, Rahman MM, Krishnan E, Choi H (2010) Epidemiology of gout in women: fifty-two-year followup of a prospective cohort. Arthritis Rheum 62:1069–1076CrossRefGoogle Scholar
  11. 11.
    DeMarco MA, Maynard JW, Huizinga MM, Baer AN, Kottgen A, Gelber AC, Coresh J (2011) Obesity and younger age at gout onset in a community-based cohort. Arthritis Care Res (Hoboken) 63:1108–1114CrossRefGoogle Scholar
  12. 12.
    Cea Soriano L, Rothenbacher D, Choi HK, Garcia Rodriguez LA (2011) Contemporary epidemiology of gout in the UK general population. Arthritis Res Ther 13:R39CrossRefGoogle Scholar
  13. 13.
    Maynard JW, Adams DeMarco MA, Baer AN, Kottgen A, Folsom AR, Coresh J, Gelber AC (2012) Incident gout in women and association with obesity in the Atherosclerosis Risk in Communities (ARIC) Study. Am J Med 125:717CrossRefGoogle Scholar
  14. 14.
    McAdams-DeMarco MA, Maynard JW, Baer AN, Coresh J (2012) Hypertension and the risk of incident gout in a population-based study: the atherosclerosis risk in communities cohort. J Clin Hypertens (Greenwich) 14:675–679CrossRefGoogle Scholar
  15. 15.
    Chen JH, Pan WH, Hsu CC, Yeh WT, Chuang SY, Chen PY, Chen HC, Chang CT, Huang WL (2013) Impact of obesity and hypertriglyceridemia on gout development with or without hyperuricemia: a prospective study. Arthritis Care Res (Hoboken) 65:133–140CrossRefGoogle Scholar
  16. 16.
    Lin KC, Lin HY, Chou P (2000) Community based epidemiological study on hyperuricemia and gout in Kin-Hu, Kinmen. J Rheumatol 27:1045–1050Google Scholar
  17. 17.
    Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB (2000) Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 283:2008–2012CrossRefGoogle Scholar
  18. 18.
    Wells G, Shea B, O’Connell D., Peterson J, Welch V, Losos M, Tugwell P (2013) The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Accessed 23 Sept 2013
  19. 19.
    DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7:177–188CrossRefGoogle Scholar
  20. 20.
    Aune D, Greenwood DC, Chan DS, Vieira R, Vieira AR, Navarro Rosenblatt DA, Cade JE, Burley VJ, Norat T (2012) Body mass index, abdominal fatness and pancreatic cancer risk: a systematic review and non-linear dose-response meta-analysis of prospective studies. Ann Oncol 23:843–852CrossRefGoogle Scholar
  21. 21.
    Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M (2008) Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 371:569–578CrossRefGoogle Scholar
  22. 22.
    Greenland S, Longnecker MP (1992) Methods for trend estimation from summarized dose-response data, with applications to meta-analysis. Am J Epidemiol 135:1301–1309Google Scholar
  23. 23.
    Bagnardi V, Zambon A, Quatto P, Corrao G (2004) Flexible meta-regression functions for modeling aggregate dose-response data, with an application to alcohol and mortality. Am J Epidemiol 159:1077–1086CrossRefGoogle Scholar
  24. 24.
    Higgins JP, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21:1539–1558CrossRefGoogle Scholar
  25. 25.
    Egger M, Davey SG, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315:629–634CrossRefGoogle Scholar
  26. 26.
    Begg CB, Mazumdar M (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics 50:1088–1101CrossRefGoogle Scholar
  27. 27.
    Matsuura F, Yamashita S, Nakamura T, Nishida M, Nozaki S, Funahashi T, Matsuzawa Y (1998) Effect of visceral fat accumulation on uric acid metabolism in male obese subjects: visceral fat obesity is linked more closely to overproduction of uric acid than subcutaneous fat obesity. Metabolism 47:929–933CrossRefGoogle Scholar
  28. 28.
    Gao B, Zhou J, Ge J, Zhang Y, Chen F, Lau WB, Wan Y, Zhang N, Xing Y, Wang L, Fu J, Li X, Jia H, Zhao X, Ji Q (2012) Association of maximum weight with hyperuricemia risk: a retrospective study of 21,414 Chinese people. PLoS ONE 7:e51186CrossRefGoogle Scholar
  29. 29.
    Glynn RJ, Campion EW, Silbert JE (1983) Trends in serum uric acid levels 1961–1980. Arthritis Rheum 26:87–93CrossRefGoogle Scholar
  30. 30.
    Villegas R, Xiang YB, Cai Q, Fazio S, Linton M, Li H, Elasy T, Zheng W, Shu XO (2010) Prevalence and determinants of hyperuricemia in middle-aged, urban Chinese men. Metab Syndr Relat Disord 8:263–270CrossRefGoogle Scholar
  31. 31.
    Yamashita S, Matsuzawa Y, Tokunaga K, Fujioka S, Tarui S (1986) Studies on the impaired metabolism of uric acid in obese subjects: marked reduction of renal urate excretion and its improvement by a low-calorie diet. Int J Obes 10:255–264Google Scholar
  32. 32.
    Zhu Y, Zhang Y, Choi HK (2010) The serum urate-lowering impact of weight loss among men with a high cardiovascular risk profile: the Multiple Risk Factor Intervention Trial. Rheumatology (Oxford) 49:2391–2399CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2014

Authors and Affiliations

  1. 1.Department of Public Health, Faculty of MedicineNorwegian University of Science and TechnologyTrondheimNorway
  2. 2.Department of Epidemiology and Biostatistics, School of Public HealthImperial College LondonLondonUK

Personalised recommendations